1494 related articles for article (PubMed ID: 25274302)
21. Methods for decoding Cas9 protospacer adjacent motif (PAM) sequences: A brief overview.
Karvelis T; Gasiunas G; Siksnys V
Methods; 2017 May; 121-122():3-8. PubMed ID: 28344037
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of duplex DNA destabilization by RNA-guided Cas9 nuclease during target interrogation.
Mekler V; Minakhin L; Severinov K
Proc Natl Acad Sci U S A; 2017 May; 114(21):5443-5448. PubMed ID: 28484024
[TBL] [Abstract][Full Text] [Related]
23. Programmable DNA cleavage in vitro by Cas9.
Karvelis T; Gasiunas G; Siksnys V
Biochem Soc Trans; 2013 Dec; 41(6):1401-6. PubMed ID: 24256227
[TBL] [Abstract][Full Text] [Related]
24. Position of Deltaproteobacteria Cas12e nuclease cleavage sites depends on spacer length of guide RNA.
Selkova P; Vasileva A; Pobegalov G; Musharova O; Arseniev A; Kazalov M; Zyubko T; Shcheglova N; Artamonova T; Khodorkovskii M; Severinov K; Fedorova I
RNA Biol; 2020 Oct; 17(10):1472-1479. PubMed ID: 32564655
[TBL] [Abstract][Full Text] [Related]
25. Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.
Komor AC; Kim YB; Packer MS; Zuris JA; Liu DR
Nature; 2016 May; 533(7603):420-4. PubMed ID: 27096365
[TBL] [Abstract][Full Text] [Related]
26. Engineered CRISPR-Cas9 nucleases with altered PAM specificities.
Kleinstiver BP; Prew MS; Tsai SQ; Topkar VV; Nguyen NT; Zheng Z; Gonzales AP; Li Z; Peterson RT; Yeh JR; Aryee MJ; Joung JK
Nature; 2015 Jul; 523(7561):481-5. PubMed ID: 26098369
[TBL] [Abstract][Full Text] [Related]
27. Structural Variation of Type I-F CRISPR RNA Guided DNA Surveillance.
Pausch P; Müller-Esparza H; Gleditzsch D; Altegoer F; Randau L; Bange G
Mol Cell; 2017 Aug; 67(4):622-632.e4. PubMed ID: 28781236
[TBL] [Abstract][Full Text] [Related]
28. Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease.
Anders C; Niewoehner O; Duerst A; Jinek M
Nature; 2014 Sep; 513(7519):569-73. PubMed ID: 25079318
[TBL] [Abstract][Full Text] [Related]
29. DNase H Activity of Neisseria meningitidis Cas9.
Zhang Y; Rajan R; Seifert HS; Mondragón A; Sontheimer EJ
Mol Cell; 2015 Oct; 60(2):242-55. PubMed ID: 26474066
[TBL] [Abstract][Full Text] [Related]
30. Phage AcrIIA2 DNA Mimicry: Structural Basis of the CRISPR and Anti-CRISPR Arms Race.
Liu L; Yin M; Wang M; Wang Y
Mol Cell; 2019 Feb; 73(3):611-620.e3. PubMed ID: 30606466
[TBL] [Abstract][Full Text] [Related]
31. Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems.
Fonfara I; Le Rhun A; Chylinski K; Makarova KS; Lécrivain AL; Bzdrenga J; Koonin EV; Charpentier E
Nucleic Acids Res; 2014 Feb; 42(4):2577-90. PubMed ID: 24270795
[TBL] [Abstract][Full Text] [Related]
32. Genetics: Cleaving RNA with Cas9.
Ghodsizadeh O
Nat Methods; 2014 Nov; 11(11):1090. PubMed ID: 25551124
[No Abstract] [Full Text] [Related]
33. The Neisseria meningitidis CRISPR-Cas9 System Enables Specific Genome Editing in Mammalian Cells.
Lee CM; Cradick TJ; Bao G
Mol Ther; 2016 Mar; 24(3):645-54. PubMed ID: 26782639
[TBL] [Abstract][Full Text] [Related]
34. Programmable RNA Cleavage and Recognition by a Natural CRISPR-Cas9 System from Neisseria meningitidis.
Rousseau BA; Hou Z; Gramelspacher MJ; Zhang Y
Mol Cell; 2018 Mar; 69(5):906-914.e4. PubMed ID: 29456189
[TBL] [Abstract][Full Text] [Related]
35. The Impact of DNA Topology and Guide Length on Target Selection by a Cytosine-Specific Cas9.
Tsui TKM; Hand TH; Duboy EC; Li H
ACS Synth Biol; 2017 Jun; 6(6):1103-1113. PubMed ID: 28277645
[TBL] [Abstract][Full Text] [Related]
36. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
[TBL] [Abstract][Full Text] [Related]
37. Mechanistic Insights into the cis- and trans-Acting DNase Activities of Cas12a.
Swarts DC; Jinek M
Mol Cell; 2019 Feb; 73(3):589-600.e4. PubMed ID: 30639240
[TBL] [Abstract][Full Text] [Related]
38. A detailed cell-free transcription-translation-based assay to decipher CRISPR protospacer-adjacent motifs.
Maxwell CS; Jacobsen T; Marshall R; Noireaux V; Beisel CL
Methods; 2018 Jul; 143():48-57. PubMed ID: 29486239
[TBL] [Abstract][Full Text] [Related]
39. Kinetic Basis for DNA Target Specificity of CRISPR-Cas12a.
Strohkendl I; Saifuddin FA; Rybarski JR; Finkelstein IJ; Russell R
Mol Cell; 2018 Sep; 71(5):816-824.e3. PubMed ID: 30078724
[TBL] [Abstract][Full Text] [Related]
40. PAM multiplicity marks genomic target sites as inhibitory to CRISPR-Cas9 editing.
Malina A; Cameron CJF; Robert F; Blanchette M; Dostie J; Pelletier J
Nat Commun; 2015 Dec; 6():10124. PubMed ID: 26644285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
